ST LOUIS, MO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)DONATE LIFE FOUNDATION, founded in 2013, is a mid-sized nonprofit in the Health Care sector that reported $12.4M in total revenue in fiscal year 2023. Revenue surged 305% from the prior year, signaling strong growth momentum. The organization ran a surplus of $8.4M, a strong 68% operating margin.
TO IMPROVE THE QUALITY OF LIFE FOR PEOPLE AFFECTED BY ORGAN AND TISSUE DONATION AND TRANSPLANTATION. TO TRANSFORM OUR COMMUNITY BY ELIMINATING THE WAITING LIST FOR ORGAN AND TISSUE TRANSPLANTS.
FAMILY HOUSE WAS OPENED IN 2013. IT PROVIDES LODGING ASSISTANCE TO PATIENTS WHO MUST RESIDE CLOSE TO THE TRANSPLANT CENTER WHILE AWAITING A TRANSPLANT OR RECEIVING CARE POST-TRANSPLANT SURGERY. IN...
FAMILY HOUSE WAS OPENED IN 2013. IT PROVIDES LODGING ASSISTANCE TO PATIENTS WHO MUST RESIDE CLOSE TO THE TRANSPLANT CENTER WHILE AWAITING A TRANSPLANT OR RECEIVING CARE POST-TRANSPLANT SURGERY. IN 2023, THE FAMILY HOUSE SUPPORTED 98 RECIPIENTS AND FAMILIES WITH OVER 6,000 NIGHTS OCCUPIED.
THE CLINICAL INNOVATION FUND SUPPORTS CLINICAL RESEARCH IN THE AREA OF ORGAN, TISSUE, AND EYE DONATION AND TRANSPLANTATION.
COMMUNITY GRANTS ARE AWARDED TO ORGANIZATIONS THAT IMPROVE THE HEALTH OF OUR COMMUNITIES THROUGH MENTAL AND PREVENTATIVE HEALTH PROGRAMS THAT IMPACT ORGAN, TISSUE, AND EYE DONATION AND...
COMMUNITY GRANTS ARE AWARDED TO ORGANIZATIONS THAT IMPROVE THE HEALTH OF OUR COMMUNITIES THROUGH MENTAL AND PREVENTATIVE HEALTH PROGRAMS THAT IMPACT ORGAN, TISSUE, AND EYE DONATION AND TRANSPLANTATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $12,376,183 | $3,055,652 | +3.1% |
| Expenses | $4,018,879 | $7,600,689 | -0.5% |
| Net Income | $8,357,304 | $-4,545,037 | -2.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT REAM MD | DIRECTOR | 1.00 |
Director
|
$2,650 | $0 | $2,650 |
| JENNIFER DAVIS | DIRECTOR | 1.00 |
Director
|
$2,300 | $0 | $2,300 |
| DWAYNE INGRAM | DIRECTOR | 1.00 |
Director
|
$2,300 | $0 | $2,300 |
| JORGE RIOPEDRE | SECRETARY/TREASURER | 1.00 |
Officer
Director
|
$2,200 | $0 | $2,200 |
| GENE RIDOLFI | VICE CHAIR | 1.00 |
Officer
Director
|
$2,000 | $0 | $2,000 |
| GABRIELLE KENNEDY | DIRECTOR | 1.00 |
Director
|
$1,800 | $0 | $1,800 |
| RON YOUNG | DIRECTOR | 1.00 |
Director
|
$1,800 | $0 | $1,800 |
| JOHN REED | DIRECTOR | 1.00 |
Director
|
$1,250 | $0 | $1,250 |
| ELLEN BARNIDGE | CHAIR | 1.00 |
Officer
Director
|
$1,000 | $0 | $1,000 |
| EMILY GIVENS | DIRECTOR | 1.00 |
Director
|
$1,000 | $0 | $1,000 |
| KEVIN LEE | PRESIDENT/CEO | 1.00 |
Director
|
$0 | $38,291 | $424,499 |
| DIANE BROCKMEIER | EMERITA PRESIDENT/CEO | 1.00 |
Director
|
$0 | $10,786 | $426,247 |
| LAUREN BRENNER | INTERIM EXECUTIVE DIRECTOR | 5.00 |
Officer
|
$0 | $29,740 | $189,675 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $12,376,183 | $4,018,879 | $85,512,459 | $8,357,304 |
| 2022 | $3,055,652 | $7,600,689 | $76,721,131 | $-4,545,037 |
| 2021 | $6,901,700 | $3,288,967 | $91,166,594 | $3,612,733 |
| 2020 | $2,346,179 | $2,896,913 | $80,555,296 | $-550,734 |
| 2019 | $1,899,427 | $2,970,806 | $76,002,545 | $-1,071,379 |
| 2018 | $20,141,511 | $3,139,235 | $66,523,773 | $17,002,276 |
Compare DONATE LIFE FOUNDATION with other nonprofits in Missouri and across the country.